Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial.
Omar EllouzeAgnès Soudry FaureMohamed RadhouaniOsama Abou-ArabEmmanuel BesnierMouhamed MoussaAmélie CransacElea KsiazekMarc-Olivier FischerPaul Michel MertesBelaid BouhemadPierre Grégoire GuinotPublished in: ESC heart failure (2021)
Levosimendan use in VA-ECMO appears to be beneficial for reducing weaning failure and mortality. The results of WEANILEVO should significantly influence decisions regarding the use of levosimendan for VA-ECMO weaning.
Keyphrases
- extracorporeal membrane oxygenation
- mechanical ventilation
- acute respiratory distress syndrome
- cardiac surgery
- respiratory failure
- double blind
- study protocol
- clinical trial
- phase iii
- acute kidney injury
- phase ii
- placebo controlled
- intensive care unit
- randomized controlled trial
- cardiovascular events
- type diabetes
- risk factors
- open label